Manufacturing
Showing 1–12 of 83 results
The past 25 years have seen a steady progression in business relationships between CDMOs and drug developers. The initial focus of identifying supply chain inefficiencies has advanced from controlling fixed costs and capacity fluctuations to gaining access to specific technologies, skills, and scientific expertise not possessed in-house. Our market research helps drug innovators understand the dynamic drug manufacturing environment, identify the right type of outsourcing model to best meet their organizations’ needs, and make smarter CDMO selection decisions based on hard data collected from outsourcing peers.
-
Sterile Injectable Drug Product Manufacturing Market Outlook: 2023-2028
$5,650.00 – $11,300.00 -
Cell & Gene Therapies Manufacturing Market Outlook (2nd Edition)
$5,650.00 – $11,300.00 -
Biologic Drug Product CDMO Benchmarking (6th Ed.)
$6,750.00 – $13,500.00 -
Small Molecule Drug Product CDMO Benchmarking (6th Ed.)
$6,750.00 – $13,500.00 -
Biologic API CDMO Benchmarking (8th Ed.)
$6,750.00 – $13,500.00 -
Small Molecule API CDMO Benchmarking (8th Ed.)
$6,750.00 – $13,500.00 -
Clinical Manufacturing Market Outlook
$5,650.00 – $11,300.00 -
Small and Midsize Biopharma Perspective on the Highly Potent API Manufacturing Market
$4,550.00 – $9,100.00 -
Clinical Logistics Benchmarking
$6,750.00 – $13,500.00 -
CDMO Outsourcing Models (4th Ed.)
$5,650.00 – $11,300.00 -
Bioprocessing Market Outlook: 2022-2027
$5,650.00 – $11,300.00 -
Clinical Logistics Market Dynamics
$5,650.00 – $11,300.00